---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-005307"
form_type: "8-K"
ticker: "RLYB"
cik: "0001739410"
company_name: "Rallybio Corp"
filed_at: "2022-04-04T23:59:59+00:00"
generated_at: "2026-06-26T09:51:12.899895+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Rallybio appoints Christine Nash and Hui Liu to board; Shannon to resign at annual meeting

## Summary
- Board size increased from 8 to 10; Christine Nash and Hui Liu appointed as directors effective April 4, 2022.
- Nash appointed to Compensation Committee; Liu appointed to Audit Committee.
- Director Timothy Shannon to resign at Rallybio's 2022 annual meeting of shareholders.
- Nash brings rare disease commercial/product launch experience; Liu brings business development and finance expertise.

## SEC filing metadata
- accession: 0000950170-22-005307
- form_type: 8-K
- ticker: RLYB
- cik: 0001739410
- company_name: Rallybio Corp
- filed_at: 2022-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/rlyb-20220401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-005307
- JSON: https://secwatch.observer/filing/0000950170-22-005307.json
- Plain text: https://secwatch.observer/filing/0000950170-22-005307.txt

## Key facts
- Executive change
  Hui Liu was appointed as Director at Rallybio Corp.
  - Action: appointed
  - Role: Director
  source text: appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm
- Executive change
  Christine A. Nash was appointed as Director at Rallybio Corp.
  - Action: appointed
  - Role: Director
  source text: appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm
- Executive change
  Timothy Shannon resigned as Director at Rallybio Corp.
  - Action: resigned
  - Role: Director
  source text: Timothy Shannon notified Rallybio that he would resign from the Board, effective at Rallybio’s 2022 annual meeting of shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.